Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.3389/FNCEL.2021.773696 | ||||
| Año | 2021 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
The progression of neurodegenerative diseases is reciprocally associated with impairments in peripheral immune responses. We investigated different contexts of selective neurodegeneration to identify specific alterations of peripheral immune cells and, at the same time, discover potential biomarkers associated to this pathological condition. Consequently, a model of human cerebellar degeneration and ataxia -the Purkinje Cell Degeneration (PCD) mouse- has been employed, as it allows the study of different processes of selective neuronal death in the same animal, i.e., Purkinje cells in the cerebellum and mitral cells in the olfactory bulb. Infiltrated leukocytes were studied in both brain areas and compared with those from other standardized neuroinflammatory models obtained by administering either gamma radiation or lipopolysaccharide. Moreover, both myeloid and lymphoid splenic populations were analyzed by flow cytometry, focusing on markers of functional maturity and antigen presentation. The severity and type of neural damage and inflammation affected immune cell infiltration. Leukocytes were more numerous in the cerebellum of PCD mice, being located predominantly within those cerebellar layers mostly affected by neurodegeneration, in a completely different manner than the typical models of induced neuroinflammation. Furthermore, the milder degeneration of the olfactory bulb did not foster leukocyte attraction. Concerning the splenic analysis, in PCD mice we found: (1) a decreased percentage of several myeloid cell subsets, and (2) a reduced mean fluorescence intensity in those myeloid markers related to both antigen presentation and functional maturity. In conclusion, the selective degeneration of Purkinje cells triggers a specific effect on peripheral immune cells, fostering both attraction and functional changes. This fact endorses the employment of peripheral immune cell populations as concrete biomarkers for monitoring different neuronal death processes.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Del Pilar, Carlos | Hombre |
Instituto de Neurociencias de Castilla y León - España
Instituto de Investigación Biomédica de Salamanca (IBSAL) - España Univ Salamanca - España Inst Biomed Res Salamanca - España |
| 2 | Lebrón-Galán, Rafael | Hombre |
Hospital Nacional de Paraplejicos - España
Servicio de Salud de Castilla-La Mancha (SESCAM) - España SESCAM Serv Salud Castile La Mancha - España Hosp Nacl Paraplejicos - España |
| 3 | Pérez-Martín, Ester | Mujer |
Instituto de Neurociencias de Castilla y León - España
Instituto de Investigación Biomédica de Salamanca (IBSAL) - España Univ Salamanca - España Inst Biomed Res Salamanca - España |
| 4 | Pérez-Revuelta, Laura | Mujer |
Instituto de Neurociencias de Castilla y León - España
Instituto de Investigación Biomédica de Salamanca (IBSAL) - España Univ Salamanca - España Inst Biomed Res Salamanca - España |
| 5 | avila-Zarza, Carmelo A. | Hombre |
Instituto de Investigación Biomédica de Salamanca (IBSAL) - España
Universidad de Salamanca - España Inst Biomed Res Salamanca - España Univ Salamanca - España Universidad de Tarapacá - Chile |
| 6 | ALONSO-PENA, JOSE RAMON | Hombre |
Instituto de Neurociencias de Castilla y León - España
Instituto de Investigación Biomédica de Salamanca (IBSAL) - España Universidad de Tarapacá - Chile Univ Salamanca - España Inst Biomed Res Salamanca - España |
| 7 | Clemente, Diego | Hombre |
Hospital Nacional de Paraplejicos - España
Servicio de Salud de Castilla-La Mancha (SESCAM) - España SESCAM Serv Salud Castile La Mancha - España Hosp Nacl Paraplejicos - España |
| 8 | Weruaga, Eduardo | Hombre |
Instituto de Neurociencias de Castilla y León - España
Instituto de Investigación Biomédica de Salamanca (IBSAL) - España Univ Salamanca - España Inst Biomed Res Salamanca - España |
| 9 | Diaz, D. | Hombre |
Instituto de Neurociencias de Castilla y León - España
Instituto de Investigación Biomédica de Salamanca (IBSAL) - España Univ Salamanca - España Inst Biomed Res Salamanca - España |
| Fuente |
|---|
| Ministerio de Economía y Competitividad |
| European Commission |
| Instituto de Salud Carlos III |
| Ministerio de Ciencia, Innovacion y Universidades |
| Regional Government of Castile and Leon |
| University of Salamanca |
| Agradecimiento |
|---|
| This work was supported by the Spanish Ministry of Economy and Competitiveness (MINECO; SAF2016-79668-R), the Regional Government of Castile and Leon (SA030P17), the University of Salamanca and the Institute of Health Carlos III (PI15/00963; PI18/00357; partially co-financed by F.E.D.E.R., European Union, “Una manera de hacer Europa”). DC and RL-G were employed by SESCAM. CP enjoyed a predoctoral grant awarded by the Spanish Ministry of Science, Innovation and Universities (FPU14/02963). EP-M holds a predoctoral grant awarded by the Spanish Ministry of Science, Innovation and Universities (FPU16/04259). LP-R holds a predoctoral grant awarded by the Regional Government of Castile and Leon (EDU/556/2019). |